CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
CYT
Delisted
CYT was delisted on the 15th of March, 2024.
30 hedge funds and large institutions have $28.5M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 10 closing their positions.
Holders
30
Holders Change
-7
Holders Change %
-18.92%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
7
Reduced
12
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NM
1
Newtyn Management
New York
|
$1.68M |
| 2 |
2
Millennium Management
New York
|
$296K |
| 3 |
E
3
Ergoteles
New York
|
$49.7K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$34.7K |
| 5 |
IAIM
5
International Assets Investment Management
Orlando,
Florida
|
$23.8K |
Top Sellers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$4.8M |
| 2 |
CCM
2
CAAS Capital Management
New York
|
$759K |
| 3 |
BBA
3
Baker Bros. Advisors
New York
|
$4.11M |
| 4 |
4
BlackRock
New York
|
$131K |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$0 |
